Clodi Martin, Saely Christoph H, Hoppichler Friedrich, Resl Michael, Steinwender Clemens, Stingl Harald, Wascher Thomas C, Winhofer-Stöckl Yvonne, Sourij Harald
Abteilung für Innnere Medizin, Konventhospital der Barmherzigen Brüder Linz, 4021, Linz, Österreich.
ICMR - Institute for Cardiovascular and Metabolic Research, Johannes Kepler Universität Linz, Linz, Österreich.
Wien Klin Wochenschr. 2019 May;131(Suppl 1):169-173. doi: 10.1007/s00508-019-1488-3.
Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with pre-existing diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended after therapy failure of metformin.
糖尿病、心血管疾病和心力衰竭之间存在动态相互作用。被诊断患有心血管疾病的患者应筛查糖尿病。对于已患有糖尿病的患者,应根据生物标志物、症状和经典危险因素进行强化心血管风险分层。对于先前诊断为动脉粥样硬化性心血管疾病的患者,在二甲双胍治疗失败后,建议使用已证实可降低主要不良心血管事件或心血管死亡率的药物。